ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Dana-Farber opens center for advanced cancer science.

April 23, 2004

Hatch Hearing Turns Up Few New Deficiencies In NCI Contract Management; DeVita Blasted On Strauss

June 5, 1981

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

NTP Board Approves $4 Million Mouse Variation Concept

November 22, 1985

President Obama Signs Spending Bill Giving NCI 2.8 Percent Increase

December 18, 2009

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990